These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11877471)

  • 1. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.
    Belke DD; Betuing S; Tuttle MJ; Graveleau C; Young ME; Pham M; Zhang D; Cooksey RC; McClain DA; Litwin SE; Taegtmeyer H; Severson D; Kahn CR; Abel ED
    J Clin Invest; 2002 Mar; 109(5):629-39. PubMed ID: 11877471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.
    Campbell FM; Kozak R; Wagner A; Altarejos JY; Dyck JR; Belke DD; Severson DL; Kelly DP; Lopaschuk GD
    J Biol Chem; 2002 Feb; 277(6):4098-103. PubMed ID: 11734553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.
    Abel ED; Kaulbach HC; Tian R; Hopkins JC; Duffy J; Doetschman T; Minnemann T; Boers ME; Hadro E; Oberste-Berghaus C; Quist W; Lowell BB; Ingwall JS; Kahn BB
    J Clin Invest; 1999 Dec; 104(12):1703-14. PubMed ID: 10606624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction.
    Sena S; Hu P; Zhang D; Wang X; Wayment B; Olsen C; Avelar E; Abel ED; Litwin SE
    J Mol Cell Cardiol; 2009 Jun; 46(6):910-8. PubMed ID: 19249310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.
    Belke DD; Larsen TS; Gibbs EM; Severson DL
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1104-13. PubMed ID: 11052966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention.
    Huggins CE; Domenighetti AA; Ritchie ME; Khalil N; Favaloro JM; Proietto J; Smyth GK; Pepe S; Delbridge LM
    J Mol Cell Cardiol; 2008 Feb; 44(2):270-80. PubMed ID: 18191142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density.
    McQueen AP; Zhang D; Hu P; Swenson L; Yang Y; Zaha VG; Hoffman JL; Yun UJ; Chakrabarti G; Wang Z; Albertine KH; Abel ED; Litwin SE
    J Mol Cell Cardiol; 2005 Dec; 39(6):882-92. PubMed ID: 16216265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter.
    Belke DD; Larsen TS; Gibbs EM; Severson DL
    Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E420-7. PubMed ID: 11171596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic loss of insulin receptors worsens cardiac efficiency in diabetes.
    Bugger H; Riehle C; Jaishy B; Wende AR; Tuinei J; Chen D; Soto J; Pires KM; Boudina S; Theobald HA; Luptak I; Wayment B; Wang X; Litwin SE; Weimer BC; Abel ED
    J Mol Cell Cardiol; 2012 May; 52(5):1019-26. PubMed ID: 22342406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
    Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
    Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial gene expression of glucose transporter 1 and glucose transporter 4 in response to uteroplacental insufficiency in the rat.
    Tsirka AE; Gruetzmacher EM; Kelley DE; Ritov VH; Devaskar SU; Lane RH
    J Endocrinol; 2001 May; 169(2):373-80. PubMed ID: 11312153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride.
    Bähr M; von Holtey M; Müller G; Eckel J
    Endocrinology; 1995 Jun; 136(6):2547-53. PubMed ID: 7750476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling.
    Sena S; Rasmussen IR; Wende AR; McQueen AP; Theobald HA; Wilde N; Pereira RO; Litwin SE; Berger JP; Abel ED
    Endocrinology; 2007 Dec; 148(12):6047-53. PubMed ID: 17823261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle.
    Ryder JW; Kawano Y; Chibalin AV; Rincón J; Tsao TS; Stenbit AE; Combatsiaris T; Yang J; Holman GD; Charron MJ; Zierath JR
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):321-8. PubMed ID: 10455018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats.
    Fischer Y; Thomas J; Rösen P; Kammermeier H
    Endocrinology; 1995 Feb; 136(2):412-20. PubMed ID: 7835271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis.
    Tian R; Abel ED
    Circulation; 2001 Jun; 103(24):2961-6. PubMed ID: 11413087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of insulin-responsive aminopeptidase expression and targeting in the insulin-responsive vesicle compartment of glucose transporter isoform 4-deficient cardiomyocytes.
    Abel ED; Graveleau C; Betuing S; Pham M; Reay PA; Kandror V; Kupriyanova T; Xu Z; Kandror KV
    Mol Endocrinol; 2004 Oct; 18(10):2491-501. PubMed ID: 15231875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency.
    Altamimi TR; Gao S; Karwi QG; Fukushima A; Rawat S; Wagg CS; Zhang L; Lopaschuk GD
    Metabolism; 2019 Sep; 98():37-48. PubMed ID: 31202835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.